DeuterOncology
Acquired- Website
- deuteroncology.com
- Total Funding
- $6.1M
- Last Round
- $6.1M Series AJan 2023
- Rounds
- 1
- Acquisition Date
- May 2026
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
DeuterOncology is a Biotech company. It has raised $6.1M in total across 1 round, most recently a $6.1M Series A round in Jan 2023. Investors include Newton Biocapital and Noshaq.
Funding & Exit History
May 2026
Sign up to see all 2 events
Funding: Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/deuteroncology"><img src="https://indexed.vc/api/badge/company/deuteroncology" alt="DeuterOncology on Indexed.vc" width="260" height="76" /></a>